Overview
No overview information available.
Indication
用于控制原发性癫痫病人的痉挛症状，预防并治疗神经外科手术中的惊厥发作。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | 70121-1390 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 7/25/2022 | |
| Wockhardt USA LLC. | 64679-730 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 12/29/2022 | |
| Pfizer Laboratories Div Pfizer Inc | 0069-6001 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 8/28/2025 | |
| West-Ward Pharmaceuticals Corp | 0143-9788 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 1/5/2018 | |
| GLENMARK PHARMACEUTICALS INC., USA | 68462-622 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 11/8/2023 | |
| Gland Pharma Limited | 68083-460 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 10/17/2023 | |
| West-Ward Pharmaceuticals Corp | 0143-9782 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 1/5/2018 | |
| Fresenius Kabi USA, LLC | 63323-403 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 5/1/2022 | |
| Amneal Pharmaceuticals LLC | 65162-998 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 12/18/2023 | |
| Wockhardt USA LLC. | 64679-729 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 12/29/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| CEREBYX | searchlight pharma inc | 02230988 | Solution - Intramuscular
,
Intravenous | 75 MG / ML | 3/1/2000 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.